Report an error

Spotted something inaccurate in “Oral JAK1 Inhibitor Povorcitinib Shows Consistent Gains in Hidradenitis Suppurativa Trials”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.